NASDAQ: MRVI

Maravai Lifesciences Holdings Inc Stock Forecast, Predictions & Price Target

The consensus among 6 Wall Street analysts covering (NASDAQ: MRVI) stock is to Strong Buy MRVI stock.

Out of 6 analysts, 3 (50%) are recommending MRVI as a Strong Buy, 2 (33.33%) are recommending MRVI as a Buy, 1 (16.67%) are recommending MRVI as a Hold, 0 (0%) are recommending MRVI as a Sell, and 0 (0%) are recommending MRVI as a Strong Sell.

If you're new to stock investing, here's how to buy Maravai Lifesciences Holdings stock.

(NASDAQ: MRVI) Maravai Lifesciences Holdings's forecast annual revenue growth rate of 2.87% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 60.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.43%.

Maravai Lifesciences Holdings's revenue in 2024 is $288,945,000.On average, 5 Wall Street analysts forecast MRVI's revenue for 2024 to be $68,771,691,711, with the lowest MRVI revenue forecast at $67,603,185,111, and the highest MRVI revenue forecast at $69,160,104,512. On average, 6 Wall Street analysts forecast MRVI's revenue for 2025 to be $75,877,257,665, with the lowest MRVI revenue forecast at $73,101,300,290, and the highest MRVI revenue forecast at $82,961,957,430.

In 2026, MRVI is forecast to generate $87,074,607,920 in revenue, with the lowest revenue forecast at $86,267,865,734 and the highest revenue forecast at $87,881,601,506.

According to 6 Wall Street analysts that have issued a 1 year MRVI price target, the average MRVI price target is $10.83, with the highest MRVI stock price forecast at $15.00 and the lowest MRVI stock price forecast at $7.00.

On average, Wall Street analysts predict that Maravai Lifesciences Holdings's share price could reach $10.83 by Apr 10, 2025. The average Maravai Lifesciences Holdings stock price prediction forecasts a potential upside of 40.14% from the current MRVI share price of $7.73.

(NASDAQ: MRVI) forecast ROE is N/A, which is considered weak.